Roche
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth largest pharmaceutical company in the world by revenue, and the leading provider of cancer treatments globally.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Accutane | Isotretinoin | 1982-05-07 | 2035 | |
| Aerobid | Flunisolide | 1984-08-17 | ||
| Alecensa | Alectinib | 2015-12-11 | 2030-2035 | |
| Arfonad | Trimethaphan camsylate | 1982-01-01 | ||
| Avastin | Bevacizumab | 2005-01-12 | ||
| Azo gantanol | Phenazopyridine, Sulfamethoxazole | 1987-09-10 | ||
| Azo gantrisin | Phenazopyridine, Sulfisoxazole | 1990-08-31 | ||
| Berocca pn | Ascorbic acid, Biotin, Cyanocobalamin, Dexpanthenol, Ergocalciferol, Folic acid, Niacinamide, Pyridoxine, Riboflavin 5'-phosphate, Thiamine, Vitamin, Vitamin a | 1985-10-10 | ||
| Bondenza (previously ibandronic acid roche) | Ibandronic acid | 2004-02-23 | — | |
| Boniva | Ibandronate | 2003-05-16 | ||
| Cellcept | Mycophenolate mofetil | 1995-05-03 |
1
2
3
4
5
6
...
8
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
19
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use